vTv Therapeutics Announces 2024 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
Clinical hold lifted for late stage cadisegliatin program for diabetesCATT1 Phase 3 trial in patients with type 1 diabetes (T1D) expected to ...
vTv Therapeutics Soars 43% as FDA Lifts Clinical Hold on Diabetes Drug Trial
The company plans to resume its CATT1 Phase 3 trial for type 1 diabetes after submitting a protocol amendment.
Seeking Alpha18d
IVW Vs. VTV: Growth May Lag, Consider Value In 2025
VTV tracks the performance of the CRSP US Large ... The health care sector, which generated mid-single-digit earnings growth in 2024, is expected to produce 18% year-over-year earnings increase ...
FDA Lifts Clinical Hold On vTv Therapeutics' Phase 3 Diabetes Trial, Stock Surges
Tv Therapeutics' Phase 3 trial for cadisegliatin in type 1 diabetes resumes after FDA lifts hold, with a revised six-month ...
vTv Therapeutics says FDA has lifted clinical hold on cadisegliatin program
Tv Therapeutics (VTVT) announced that the United States Food and Drug Administration has lifted the clinical hold on the cadisegliatin ...
VTV1mon
Vietnam News Agency wins two first prizes at OANA Awards 2024
VTV.vn - The Vietnam News Agency (VNA) won two first prizes at the Organisation of Asia-Pacific News Agencies (OANA) Awards 2024, as announced by ...
VTV1mon
Increasing technology content in Vietnamese exports
Vietnam’s electronic goods accounted for 31.9% of the country’s total export value and rose to 34.3% in 2024, far surpassing ...
Morningstar4d
vTv Therapeutics Announces 2024 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
HIGH POINT, N.C., March 20, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq ... for the fourth quarter and year ended December 31, 2024, and provided an update on recent corporate developments.